Recombinant Human ARHGEF4 293 Cell Lysate
Cat.No. : | ARHGEF4-8730HCL |
- Specification
- Gene Information
- Related Products
Description : | Antigen standard for Rho guanine nucleotide exchange factor (GEF) 4 (ARHGEF4), transcript variant 1 is a lysate prepared from HEK293T cells transiently transfected with a TrueORF gene-carrying pCMV plasmid and then lysed in RIPA Buffer. Protein concentration was determined using a colorimetric assay. The antigen control carries a C-terminal Myc/DDK tag for detection. |
Source : | HEK 293 cells |
Species : | Human |
Components : | This product includes 3 vials: 1 vial of gene-specific cell lysate, 1 vial of control vector cell lysate, and 1 vial of loading buffer. Each lysate vial contains 0.1 mg lysate in 0.1 ml (1 mg/ml) of RIPA Buffer (50 mM Tris-HCl pH7.5, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% NP40). The loading buffer vial contains 0.5 ml 2X SDS Loading Buffer (125 mM Tris-Cl, pH6.8, 10% glycerol, 4% SDS, 0.002% Bromophenol blue, 5% beta-mercaptoethanol). |
Size : | 0.1 mg |
Storage Instruction : | Store at -80°C. Minimize freeze-thaw cycles. After addition of 2X SDS Loading Buffer, the lysates can be stored at -20°C. Product is guaranteed 6 months from the date of shipment. |
Applications : | ELISA, WB, IP. WB: Mix equal volume of lysates with 2X SDS Loading Buffer. Boil the mixture for 10 min before loading (for membrane protein lysates, incubate the mixture at room temperature for 30 min). Load 5 ug lysate per lane. |
Gene Name : | ARHGEF4 Rho guanine nucleotide exchange factor (GEF) 4 [ Homo sapiens ] |
Official Symbol : | ARHGEF4 |
Synonyms : | ARHGEF4; Rho guanine nucleotide exchange factor (GEF) 4; rho guanine nucleotide exchange factor 4; APC stimulated guanine nucleotide exchange factor; ASEF; KIAA1112; STM6; APC-stimulated guanine nucleotide exchange factor 1; GEF4; ASEF1; |
Gene ID : | 50649 |
mRNA Refseq : | NM_015320 |
Protein Refseq : | NP_056135 |
MIM : | 605216 |
UniProt ID : | Q9NR80 |
Chromosome Location : | 2q22 |
Pathway : | Cell death signalling via NRAGE, NRIF and NADE, organism-specific biosystem; G alpha (12/13) signalling events, organism-specific biosystem; GPCR downstream signaling, organism-specific biosystem; NRAGE signals death through JNK, organism-specific biosystem; Regulation of Actin Cytoskeleton, organism-specific biosystem; Regulation of actin cytoskeleton, organism-specific biosystem; Regulation of actin cytoskeleton, conserved biosystem; |
Function : | Rac guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; guanyl-nucleotide exchange factor activity; protein binding; protein domain specific binding; |
Products Types
◆ Recombinant Protein | ||
ARHGEF4-787H | Recombinant Human ARHGEF4 protein, GST-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (15)
Ask a questionYes, ARHGEF4 interacts with several other proteins to mediate its functions. It has been found to interact with Rho GTPases, as well as other signaling molecules and cytoskeletal proteins, such as actin and myosin.
Yes, ARHGEF4 does have isoforms and splice variants. Different isoforms may vary in their domain structure, protein interactions, or expression patterns. These isoforms may contribute to the diversity of functions associated with ARHGEF4.
Yes, ARHGEF4 interacts with multiple proteins and molecules to regulate various cellular processes. For example, it can interact with Rho GTPases, activating or inactivating them in response to upstream signaling cues. ARHGEF4 can also interact with other signaling molecules like kinases and phosphatases, as well as cellular adhesion proteins and cytoskeleton-associated proteins, thereby influencing cell adhesion and migration.
Limited information is available regarding specific mutations or genetic variations in ARHGEF4 and their associations with diseases. Further research and genetic studies are necessary to understand if variations in ARHGEF4 contribute to certain disorders.
Targeting ARHGEF4 for therapeutic purposes is an area of ongoing research. Since dysregulation of ARHGEF4 is associated with various diseases, developing strategies to modulate its activity or expression could have therapeutic potential. However, further studies are needed to fully understand ARHGEF4's role in diseases and to explore potential therapeutic interventions targeting this protein.
Yes, ARHGEF4 has been the subject of scientific research, and there is literature available on its functions, interactions, and associations with diseases. However, more studies are needed to fully elucidate its role in cellular processes and its relevance to human health and diseases.
Dysregulation of ARHGEF4 has been implicated in several diseases and pathologies. For example, abnormal expression or function of ARHGEF4 has been observed in certain cancers, including breast, lung, and colorectal cancer, where it contributes to tumor progression and metastasis. ARHGEF4 dysregulation has also been linked to neurological disorders, such as Alzheimer's disease, where it may play a role in synaptic dysfunction and neuronal degeneration.
Due to its involvement in diseases like cancer and neurodevelopmental disorders, targeting ARHGEF4 may have potential therapeutic implications. However, further research is required to better understand its precise molecular mechanisms and validate its therapeutic potential.
Yes, ARHGEF4 has been implicated in several diseases and pathological conditions. It has been associated with cancer progression, specifically in metastasis, as well as neurodevelopmental disorders and neurodegenerative diseases.
While information on animal models or knockout studies specifically targeting ARHGEF4 is limited, there have been studies involving the modulation of Rho GTPases or related pathways that indirectly impact ARHGEF4 function. These studies often provide insights into the cellular and physiological consequences of ARHGEF4 dysregulation.
Yes, the expression of ARHGEF4 can be dynamically regulated during development. It is expressed in various tissues and cell types, and its expression levels may change during different stages of development or in response to specific signaling cues.
ARHGEF4 is widely expressed in various tissues and cell types. It has been detected in the brain, heart, liver, lungs, and skeletal muscles, among others. Its expression levels can vary in different tissues and during different stages of development.
ARHGEF4 is not considered an essential protein for basic cellular function. However, it plays important roles in specific cellular processes, such as cell migration and cytoskeletal dynamics, which are crucial for various physiological functions.
ARHGEF4 is primarily involved in the regulation of Rho family GTPases, specifically RhoA, Rac1, and Cdc42. These GTPases play critical roles in cellular processes such as cell migration, cell adhesion, cytoskeletal organization, and cell polarity.
To the best of our knowledge, there are no specific small molecules or inhibitors that directly target ARHGEF4 activity reported in the literature. However, targeting the downstream effector proteins or pathways regulated by ARHGEF4, such as Rho GTPases, may indirectly modulate ARHGEF4-mediated functions.
Customer Reviews (8)
Write a reviewExtensive research has been conducted on ARHGEF4, making it relatively accessible and well-understood in terms of its structure and functions.
ARHGEF4 protein is highly recommended for use in various research applications, including ELISA and protein electron microscopy structure analysis.
The manufacturer's excellent technical support, commitment to innovation, and customer-centric approach further reinforce its suitability for my research.
With their support, I can confidently explore the intricacies of ARHGEF4 and make significant contributions to the understanding of its functions in various biological processes.
This existing knowledge base provides a solid foundation for designing experiments and interpreting results, ultimately enhancing the efficiency and reliability of trials involving ARIH1L protein.
ARHGEF4 protein's remarkable performance in ELISA and protein electron microscopy structure analysis positions it as a valuable tool in various fields, including cardiovascular research, developmental biology, and molecular medicine.
ARHGEF4 protein's utility extends to protein electron microscopy structure analysis, where it plays a crucial role in investigating the detailed architecture and conformational changes of proteins.
It exhibits exceptional performance in ELISA assays, making it an excellent choice for researchers studying angiopoietins, angiogenesis, or vascular biology.
Ask a Question for All ARHGEF4 Products
Required fields are marked with *
My Review for All ARHGEF4 Products
Required fields are marked with *
Inquiry Basket